| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 11/02/1994 | EP0621898A1 Chimeric immunogens |
| 11/02/1994 | EP0382736B1 Receptor membranes |
| 11/02/1994 | CA2122556A1 Dna fragment, vector containing the dna fragment, transformant transformed with the vector and process for producing protein using the vector |
| 10/27/1994 | WO1994024163A2 Bispecific antigen-binding molecules |
| 10/27/1994 | CA2160224A1 Bispecific antigen-binding molecules |
| 10/26/1994 | EP0621340A1 Product and process for the production and purification of recombinant polypeptides |
| 10/26/1994 | EP0620854A1 Expression and purification of recombinant soluble tissue factor |
| 10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
| 10/26/1994 | EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 10/26/1994 | CN1094093A Progenitor B cell stinulating factor |
| 10/26/1994 | CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 10/25/1994 | US5359046 Chimeric chains for receptor-associated signal transduction pathways |
| 10/25/1994 | US5358851 Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection |
| 10/19/1994 | EP0620276A1 Humanised antibodies |
| 10/19/1994 | EP0620010A1 HIV related peptides |
| 10/19/1994 | EP0620009A1 HIV related peptides |
| 10/19/1994 | EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins |
| 10/19/1994 | EP0619842A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 10/19/1994 | EP0619839A1 Novel polypeptides for promoting cell attachment |
| 10/19/1994 | EP0515536A4 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
| 10/18/1994 | US5356875 Anti-thrombin polypeptides and pharmaceutical compositions thereof |
| 10/13/1994 | WO1994023040A1 Methods and dna expression systems for over-expression of proteins in host cells |
| 10/13/1994 | WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II |
| 10/13/1994 | WO1994023024A1 Dna encoding cobra c3, cvf1, and cvf2 |
| 10/13/1994 | WO1994022916A1 Biologically active polypeptide fusion dimers |
| 10/13/1994 | WO1994018332A3 Anthrax toxin fusion proteins and uses thereof |
| 10/13/1994 | CA2160127A1 Dna encoding cobra c3, cvf1, and cvf2 |
| 10/13/1994 | CA2159499A1 Biologically active polypeptide fusion dimers |
| 10/13/1994 | CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii |
| 10/12/1994 | EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
| 10/12/1994 | EP0618816A1 Further improvements relating to the radiolabelling of proteins |
| 10/12/1994 | EP0555336A4 Homobifunctional agents for coupling enzymes and the like to antibodies and the like. |
| 10/11/1994 | US5354847 Chimeric antibody with specificity to human tumor antigen |
| 10/11/1994 | US5354844 Protein-polycation conjugates |
| 10/11/1994 | US5354843 Bone disorders; antiarthritic agents; medical diagnosis of thyroid cancer; automatic solid phase synthesis; resin peptides |
| 10/11/1994 | US5354691 Immunogens inducing resistance to autoimmune arthritis |
| 10/11/1994 | US5354661 Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection |
| 10/11/1994 | CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies |
| 10/05/1994 | EP0618231A1 Immunologically active conjugates and a method for their preparation |
| 10/05/1994 | EP0618227A1 Biologically active polypeptide fusion dimers |
| 10/05/1994 | EP0617967A1 Therapeutic reagents based on unique sequences within the variable region of the T cell receptor |
| 10/05/1994 | EP0617706A1 Multivalent antigen-binding proteins |
| 10/04/1994 | US5352604 Alkaline proteolytic enzyme and method of production |
| 09/30/1994 | WO1993019172A1 Methods for producing members of specific binding pairs |
| 09/30/1994 | CA2131151A1 Methods for producing members of specific binding pairs |
| 09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
| 09/28/1994 | EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins |
| 09/28/1994 | EP0616640A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/28/1994 | EP0467998B1 Peptides from retinoblastoma gene products and antibodies thereto |
| 09/28/1994 | CN1092812A Vaccines |
| 09/20/1994 | US5349053 Chimeric ligand/immunoglobulin molecules and their uses |
| 09/20/1994 | US5348876 DNA molecules and codes with polypeptide sequences |
| 09/15/1994 | WO1994020625A1 Method for inducing tumor cell death |
| 09/15/1994 | WO1994020540A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 09/15/1994 | WO1994020464A1 Coupling method using selective amination of maleimide |
| 09/15/1994 | WO1994020079A1 Human brain phosphodiesterase |
| 09/15/1994 | WO1994017192A3 Lysosomal targeting of immunogens |
| 09/15/1994 | WO1994004688A3 Cationic peptides and method for production |
| 09/15/1994 | CA2654420A1 Cloning and recombinant production of vespid venom enzymes, such as phospholiphase and hyaluronidase, and immunological therapies based thereon |
| 09/15/1994 | CA2157010A1 Method for inducing tumor cell death |
| 09/15/1994 | CA2156704A1 Coupling method using selective amination of maleimide |
| 09/14/1994 | EP0614985A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
| 09/14/1994 | EP0614981A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/14/1994 | EP0614973A1 Polypeptide useful in diagnosis of coccidia infection and recombinant-DNA methods for manufacturing same |
| 09/14/1994 | EP0614531A1 Process for detecting p53-specific antibodies |
| 09/14/1994 | EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
| 09/14/1994 | EP0614486A1 Targeted delivery of virus vector to mammalian cells |
| 09/14/1994 | EP0614465A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613497A1 Lymphoid cd30-antigen. |
| 09/07/1994 | EP0462210B1 Vaccines for nontypable haemophilus influenzae |
| 09/07/1994 | CN1025860C Cross reactive and protective epitope of cicumsporozoite proteins |
| 09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/01/1994 | WO1994019021A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | WO1994019017A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 09/01/1994 | CA2156421A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 09/01/1994 | CA2155953A1 Protein conjugates, compositions containing them and their applications as medicament |
| 08/31/1994 | EP0613006A1 Antibodies to cachectin and immunoassays |
| 08/31/1994 | EP0612847A2 Anti microbial proteins |
| 08/31/1994 | EP0612846A1 G-CSF analog compositions and methods |
| 08/31/1994 | EP0612845A2 Purified opioid receptor |
| 08/31/1994 | EP0612348A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 08/31/1994 | EP0612251A1 Stabilised antibodies |
| 08/31/1994 | EP0506833B1 Method of preparation of hirudin |
| 08/25/1994 | DE4337197C1 Process for the selective preparation of hybridoma cell lines which produce monoclonal antibodies with high cytotoxicity against human CD16 antigen, and the preparation of bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody for therapy of human tumours |
| 08/25/1994 | CA2116201A1 Anti-microbial proteins |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | EP0461165B1 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
| 08/23/1994 | US5340921 Γ, δT cell receptor and methods and detection |
| 08/23/1994 | US5340731 Method of preparing a B-1,4 glycan matrix containing a bound fusion protein |
| 08/18/1994 | WO1994018560A1 Method of assaying human tau protein, kit therefor, and diagnostic method |
| 08/18/1994 | WO1994018332A2 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | WO1994018330A1 Immobilized proteins with specific binding capacities and their use in processes and products |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994014960A3 Protocadherin, their autibodies and uses |
| 08/18/1994 | CA2155514A1 Anthrax toxin fusion proteins and uses thereof |
| 08/17/1994 | EP0611080A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone H1 |
| 08/17/1994 | EP0610436A1 Hepatitis-c virus testing |